Controlled Substances: Florida and Federal Scheduling, Prescribing, Dispensing, and Reporting
Controlled substance questions blend federal DEA rules (21 CFR) with Florida Chapter 893. Candidates must know the schedules and which drugs sit in each, the DEA registration requirement, and the Florida PDMP (E-FORCSE) reporting duty. A central trap is the prescription monitoring obligation: dispensers must report controlled substance dispensings to E-FORCSE within the statutory timeframe, and questions often test whether a particular drug (e.g., a Schedule V or a non-controlled gabapentinoid) triggers reporting. Another trap is refill and quantity limits for Schedule II versus III–V, and the rules for emergency oral Schedule II prescriptions (limited quantity, written follow-up required). Florida also restricts prescribing to minors and requires informed consent documentation in defined circumstances. Watch for the distinction between dispensing and administering, and the requirement that only a pharmacist may dispense controlled substances. Rule of thumb: Schedule II = no refills; if a question offers refills on a CII, the answer is wrong. Worked example: a patient presents a CII prescription dated 30 days ago. Florida limits the window for filling CII prescriptions; the pharmacist must check the applicable time limit before dispensing and cannot simply fill it because it "looks valid."